A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity

被引:105
作者
Kontush, A
de Faria, EC
Chantepie, S
Chapman, MJ
机构
[1] Hop Pitie, INSERM, Natl Inst Hlth & Med Res, Dyslipoproteinemia & Atherosclerosis Res Unit,U55, F-75651 Paris, France
[2] Campinas Univ Hosp, Sch Med, Campinas, Brazil
关键词
HDL particle heterogeneity; atherosclerosis; isoprostanes; lipid hydroperoxides;
D O I
10.1016/j.atherosclerosis.2005.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Low levels of high density lipoprotein-cholesterol (HDL-C) are highly prevalent in subjects presenting premature atherosclerosis. It is indeterminate as to whether high cardiovascular risk in low HDL-C subjects occurs concomitantly with elevated oxidative stress and/or with biologically dysfunctional HDL particles. Methods and results: Systemic oxidative stress (as plasma 8-isoprostanes) was 2.3-fold elevated (p < 0.05) in normocholesterolemic, normotriglyceridemic, normoglycernic low HDL-C subjects (plasma HDL-C, <40 mg/dL; n = 8) as compared to nonnolipidemic controls (n = 15). HDL subfractions (HDL2b, 2a, 3a, 3b and 3c) isolated by density gradient ultracentrifugation from low HDL-C subjects displayed significantly lower (-21 to -43%, p < 0.05) specific antioxidative activity (sAA; capacity to protect LDL from oxidation on a unit particle mass or on a particle number basis) as compared to controls. Altered chemical composition (core triglyceride enrichment, cholesteryl ester depletion) paralleled antioxidative dysfunction of HDL subfractions. Plasma 8-isoprostane levels negatively correlated with sAA of HDL subfractions and positively correlated with the total cholesterol/HDL-C ratio, which was significantly elevated in the low HDL-C phenotype. Conclusions: Low HDL-C subjects display elevated oxidative stress and possess HDL particle subspecies with attenuated intrinsic antioxidative activity which is intimately related to their altered chemical composition. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 42 条
[1]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[2]   Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells [J].
Ashby, DT ;
Rye, KA ;
Clay, MA ;
Vadas, MA ;
Gamble, JR ;
Barter, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1450-1455
[3]   ACTIVITIES OF LIPOPROTEIN-LIPASE AND HEPATIC TRIGLYCERIDE LIPASE IN POSTHEPARIN PLASMA OF PATIENTS WITH LOW CONCENTRATIONS OF HDL CHOLESTEROL [J].
BLADES, B ;
VEGA, GL ;
GRUNDY, SM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1227-1235
[4]   HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS [J].
BOWRY, VW ;
STANLEY, KK ;
STOCKER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10316-10320
[5]   Clinical significance of high-density lipoproteins and the development of atherosclerosis: Focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter [J].
Brewer, HB ;
Santamarina-Fojo, S .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4B) :10K-16K
[6]   Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels [J].
Brites, FD ;
Bonavita, CD ;
De Geitere, C ;
Cloës, M ;
Delfly, B ;
Yael, MJ ;
Fruchart, JC ;
Wikinski, RW ;
Castgro, GR .
ATHEROSCLEROSIS, 2000, 152 (01) :181-192
[7]   Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL [J].
Chancharme, L ;
Thérond, P ;
Nigon, F ;
Lepage, S ;
Couturier, M ;
Chapman, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :810-820
[8]   Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C [J].
Chapman, MJ ;
Assmann, G ;
Fruchart, JC ;
Shepherd, J ;
Sirtori, C .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) :1253-1268
[9]  
CHAPMAN MJ, 1981, J LIPID RES, V22, P339
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497